237 related articles for article (PubMed ID: 10462449)
1. Human selenium-dependent thioredoxin reductase from HeLa cells: properties of forms with differing heparin affinities.
Gorlatov SN; Stadtman TC
Arch Biochem Biophys; 1999 Sep; 369(1):133-42. PubMed ID: 10462449
[TBL] [Abstract][Full Text] [Related]
2. Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity.
Lee SR; Bar-Noy S; Kwon J; Levine RL; Stadtman TC; Rhee SG
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2521-6. PubMed ID: 10688911
[TBL] [Abstract][Full Text] [Related]
3. Human thioredoxin reductase from HeLa cells: selective alkylation of selenocysteine in the protein inhibits enzyme activity and reduction with NADPH influences affinity to heparin.
Gorlatov SN; Stadtman TC
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8520-5. PubMed ID: 9671710
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of expression of cytosolic and mitochondrial thioredoxin reductase in rat liver and kidney.
Crosley LK; Méplan C; Nicol F; Rundlöf AK; Arnér ES; Hesketh JE; Arthur JR
Arch Biochem Biophys; 2007 Mar; 459(2):178-88. PubMed ID: 17291446
[TBL] [Abstract][Full Text] [Related]
5. Heparin-binding properties of selenium-containing thioredoxin reductase from HeLa cells and human lung adenocarcinoma cells.
Liu SY; Stadtman TC
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6138-41. PubMed ID: 9177183
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mammalian thioredoxin reductase by black tea and its constituents: implications for anticancer actions.
Du Y; Wu Y; Cao X; Cui W; Zhang H; Tian W; Ji M; Holmgren A; Zhong L
Biochimie; 2009 Mar; 91(3):434-44. PubMed ID: 19059456
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of green tea extract and (-)-epigallocatechin-3-gallate on mammalian thioredoxin reductase and HeLa cell viability.
Wang Y; Zhang H; Holmgren A; Tian W; Zhong L
Oncol Rep; 2008 Dec; 20(6):1479-87. PubMed ID: 19020731
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to human thioredoxin reductase.
Söderberg A; Sahaf B; Holmgren A; Rosén A
Biochem Biophys Res Commun; 1998 Aug; 249(1):86-9. PubMed ID: 9705836
[TBL] [Abstract][Full Text] [Related]
9. High-level expression in Escherichia coli of selenocysteine-containing rat thioredoxin reductase utilizing gene fusions with engineered bacterial-type SECIS elements and co-expression with the selA, selB and selC genes.
Arnér ES; Sarioglu H; Lottspeich F; Holmgren A; Böck A
J Mol Biol; 1999 Oct; 292(5):1003-16. PubMed ID: 10512699
[TBL] [Abstract][Full Text] [Related]
10. Highly active dimeric and low-activity tetrameric forms of selenium-containing rat thioredoxin reductase 1.
Rengby O; Cheng Q; Vahter M; Jörnvall H; Arnér ES
Free Radic Biol Med; 2009 Apr; 46(7):893-904. PubMed ID: 19146949
[TBL] [Abstract][Full Text] [Related]
11. The role of thioredoxin reductase activity in selenium-induced cytotoxicity.
Madeja Z; Sroka J; Nyström C; Björkhem-Bergman L; Nordman T; Damdimopoulos A; Nalvarte I; Eriksson LC; Spyrou G; Olsson JM; Björnstedt M
Biochem Pharmacol; 2005 Jun; 69(12):1765-72. PubMed ID: 15935149
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial thioredoxin reductase purification, inhibitor studies, and role in cell signaling.
Rigobello MP; Bindoli A
Methods Enzymol; 2010; 474():109-22. PubMed ID: 20609907
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by the overexpression of an alternative splicing variant of mitochondrial thioredoxin reductase.
Chang EY; Son SK; Ko HS; Baek SH; Kim JH; Kim JR
Free Radic Biol Med; 2005 Dec; 39(12):1666-75. PubMed ID: 16298692
[TBL] [Abstract][Full Text] [Related]
14. A 35 kDa NAD(P)H oxidase previously isolated from the archaeon Sulfolobus solfataricus is instead a thioredoxin reductase.
Ruocco MR; Ruggiero A; Masullo L; Arcari P; Masullo M
Biochimie; 2004 Dec; 86(12):883-92. PubMed ID: 15667938
[TBL] [Abstract][Full Text] [Related]
15. A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity.
Tamura T; Stadtman TC
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1006-11. PubMed ID: 8577704
[TBL] [Abstract][Full Text] [Related]
16. Truncated mutants of human thioredoxin reductase 1 do not exhibit glutathione reductase activity.
Urig S; Lieske J; Fritz-Wolf K; Irmler A; Becker K
FEBS Lett; 2006 Jun; 580(15):3595-600. PubMed ID: 16750198
[TBL] [Abstract][Full Text] [Related]
17. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
[TBL] [Abstract][Full Text] [Related]
18. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
[TBL] [Abstract][Full Text] [Related]
19. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
[TBL] [Abstract][Full Text] [Related]
20. A stable mixed disulfide between thioredoxin reductase and its substrate, thioredoxin: preparation and characterization.
Wang PF; Veine DM; Ahn SH; Williams CH
Biochemistry; 1996 Apr; 35(15):4812-9. PubMed ID: 8664271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
